Format

Send to

Choose Destination
Nat Rev Cancer. 2003 Jul;3(7):502-16.

Ovarian cancer: strategies for overcoming resistance to chemotherapy.

Author information

1
Section of Medicine, Institute for Cancer Research, Sutton, Surrey SM2 5NG, UK. skaye@icr.ac.uk

Abstract

Ovarian cancer is responsible for 4% of deaths from cancer in women. Treatment comprises a combination of surgery and chemotherapy, but patients typically experience disease relapse within 2 years of the initial treatment. Further treatment can extend survival, although relapse eventually occurs again. A better understanding of the mechanisms that underlie this drug resistance should allow treatment to be optimized, so that substantial improvements in the outlook for women with this disease can be achieved.

PMID:
12835670
DOI:
10.1038/nrc1123
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center